Review




Structured Review

Epigenomics ag replication timing and epigenomic data
a Quantile-quantile plot of fishHook p -values to assess significance of gene mutational burden after removing confounders. The p -values were obtained by comparing observed mutational rate to the right tail (one-sided) of the expected mutational rates derived from a gamma-Poisson model of genome-wide mutational density and the covariates replication timing, <t>epigenetic</t> state, and sequence context. In the first stage of CIRCLE, six significant genes were identified below a false-discovery threshold (FDR < 0.1). b Odds ratios (ORs) of response to ICB therapy in patients with a high or moderate impact mutation in the indicated gene as compared to patients that do not have a high or moderate mutation in the given gene ( n = 272 patients). Error bars indicate the 95% confidence interval of the odds ratio. ORs greater than one indicate enrichment in responders and ORs less than one indicate enrichment in non-responders. Statistical significance was tested using a two-sided Wald’s test of coefficients with multiple-hypothesis correction (FDR < 0.2).
Replication Timing And Epigenomic Data, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication+data+and+code/pmc09270330-217-3-12?v=Epigenomics+ag
Average 90 stars, based on 1 article reviews
replication timing and epigenomic data - by Bioz Stars, 2026-07
90/100 stars

Images

1) Product Images from "Recurrent somatic mutations as predictors of immunotherapy response"

Article Title: Recurrent somatic mutations as predictors of immunotherapy response

Journal: Nature Communications

doi: 10.1038/s41467-022-31055-3

a Quantile-quantile plot of fishHook p -values to assess significance of gene mutational burden after removing confounders. The p -values were obtained by comparing observed mutational rate to the right tail (one-sided) of the expected mutational rates derived from a gamma-Poisson model of genome-wide mutational density and the covariates replication timing, epigenetic state, and sequence context. In the first stage of CIRCLE, six significant genes were identified below a false-discovery threshold (FDR < 0.1). b Odds ratios (ORs) of response to ICB therapy in patients with a high or moderate impact mutation in the indicated gene as compared to patients that do not have a high or moderate mutation in the given gene ( n = 272 patients). Error bars indicate the 95% confidence interval of the odds ratio. ORs greater than one indicate enrichment in responders and ORs less than one indicate enrichment in non-responders. Statistical significance was tested using a two-sided Wald’s test of coefficients with multiple-hypothesis correction (FDR < 0.2).
Figure Legend Snippet: a Quantile-quantile plot of fishHook p -values to assess significance of gene mutational burden after removing confounders. The p -values were obtained by comparing observed mutational rate to the right tail (one-sided) of the expected mutational rates derived from a gamma-Poisson model of genome-wide mutational density and the covariates replication timing, epigenetic state, and sequence context. In the first stage of CIRCLE, six significant genes were identified below a false-discovery threshold (FDR < 0.1). b Odds ratios (ORs) of response to ICB therapy in patients with a high or moderate impact mutation in the indicated gene as compared to patients that do not have a high or moderate mutation in the given gene ( n = 272 patients). Error bars indicate the 95% confidence interval of the odds ratio. ORs greater than one indicate enrichment in responders and ORs less than one indicate enrichment in non-responders. Statistical significance was tested using a two-sided Wald’s test of coefficients with multiple-hypothesis correction (FDR < 0.2).

Techniques Used: Derivative Assay, Genome Wide, Sequencing, Mutagenesis



Similar Products

90
Mendeley Ltd replication code/pseudo data
Replication Code/Pseudo Data, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication+data+and+code/10__1016_slash_j__jfineco__2023__103777-570-0-14?v=Mendeley+Ltd
Average 90 stars, based on 1 article reviews
replication code/pseudo data - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Mendeley Ltd replication data and code
Replication Data And Code, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication+data+and+code/10__1016_slash_j__jdeveco__2021__102665-506-21-39?v=Mendeley+Ltd
Average 90 stars, based on 1 article reviews
replication data and code - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Drott Medizintechnik GmbH replication data and code
Replication Data And Code, supplied by Drott Medizintechnik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/replication+data+and+code/10__1080_slash_13698249__2018__1525677-165-25-20?v=Drott+Medizintechnik+GmbH
Average 90 stars, based on 1 article reviews
replication data and code - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results